Here are Monday’s biggest analyst calls: Nvidia, Micron, Ferrari, Rocket Lab, DataDog & more
Here are Monday’s biggest calls on Wall Street: Morgan Stanley initiates Onto Innovation as overweight The firm said the semis company has upside to consensus. “We think there is upside to street estimates as well as scope for multiple re-rating for ONTO, a process control SPE [special purpose entity] company involved in both the back-end and front-end, driven by three drivers…” Needham initiates Ceva as buy Needham said the IP solutions for the semis industry is an AI beneficiary. “We are launching coverage of CEVA, Inc. (ticker: CEVA) with a Buy rating and a price target of $55, equal to 70x P/E on our CY27 EPS estimate.” UBS initiates Jade Biosciences as buy UBS said the biotech company has best-in-class potential. “We also think the FDA is becoming more amenable to accepting shorter i.e.,12- month eGFR kidney function data for full approval too which should help JADE to accelerate enrollment of their pivotal study.” JPMorgan initiates Esco Technologies as overweight JPMorgan said the industrial company has a differentiated offering. “We initiate coverage of ESCO Technologies (E SE) with an Overweight rating and a Dec. 2027 price target of $420, implying ~33% upside potential from current levels.” Baird names Capital One a fresh pick Baird said the stock has a slew of positive catalysts ahead. “From our perspective, COF shares represent one of the best ideas in our coverage, as market participants remain focused on narratives around a potentially weak consumer, elevated DFS investment spend, while perhaps overlooking the stock’s pedestrian valuation, COF’s enviable capital position and earnings flexibility.” Bank of America initiates TeraWulf as buy The firm said the bitcoin miner is also a data center beneficiary. “We initiate coverage of TeraWulf (WULF) with a Buy rating and a $34 price objective (PO) based on a 9.5x EV/Revenue.” Morgan Stanley upgrades Ferrari to overweight from equal weight Morgan Stanley upgraded the stock and raised its price target to $438 per share from $388. “We believe the de-rating now overstates brand risk. Checks show tha t Ferrari is intact, residuals bottoming, Luce priced in, and wealth creation plus pipeline optionality support a re-rating.” Read more. Citi upgrades Paychex to buy from neutral Citi said the company is well positioned for growth. “Led by the recent surge in bookings growth and the anniversarying/synergies from the Paycor acquisition, we expect PAYX organic rev growth to accelerate in FY27.” Jefferies upgrades HawkEye 360 to buy from hold Jefferies said buy the dip in the aerospace company. “With HAWK shares down 25% since June 1 (vs. S & P -2%) and now offering 43% upside potential to our $34 PT, we upgrade to Buy from Hold.” KeyBanc upgrades Rocket Lab & Firefly Aerospace to overweight from sector weight Key said both space stocks are beneficiaries of the SpaceX IPO. “There are not enough rockets to meet the demand of spacecraft/satellites that want to be in orbit. Our supply/demand model shows it will take over a decade to reach equilibrium. This assumes full success of Starship, as much of SPCX’s launch capacity will be used internally and Falcon 9 will sunset as Starship progresses. This presents an opportunity for future medium lift launch vehicles (e.g., RKLB’s Neutron, FLY’s Ec lipse), which could represent tens of billions of annual revenue dollars in the coming years.” Roth initiates Better Home & Finance as buy Roth said the mortgage lender is well positioned. “We believe Better is positioned to be a structurally lower-cost winner as it transitions from a cyclical direct-to-consumer mortgage lender into an AI-native origination platform with distribution partners. Its proprietary AI-native Tinman system, marquee partnerships with Credit Karma and ChatGPT, and improving unit economics give it a clear edge versus legacy lenders, in our opinion.” TD Cowen reiterates Micron as buy TD Cowen raised its price target on Micron ahead of earnings to $1,500 from $660. “Expecting $23 EPS for MayQ (St. at $20) and $27 for AugQ (St. at $24), broadly consistent with our April field work.” Read more. Citi downgrades Old Dominion to sell from neutral and C.H. Robinson to neutral from buy The firm downgraded several trucking companies on Monday and said optimism is already priced in. “Based on this analysis, we move ODFL t o Sell. We also downgrade SAIA, KNX and CHRW to Neutral, as it becomes increasingly difficult to identify meaningful upside on fundamentals. With many trucking stocks near all time highs, we believe elevated optimism appears reflected in valuations.” Goldman Sachs reinstates 3M as buy Goldman reinstated coverage of the stock and upgraded 3M and says its shares are cheap. “The bottom line is that we see MMM as an intriguing self-help story with improving organic growth and potential upside from liability resolution trading at an inexpensive valuation.” Goldman Sachs initiates Lincoln International as buy Goldman said the investment company has “robust” growth. “We initiate coverage of independent investment bank (IBank ) Lincoln International (L CLN) with a Buy rating and a $27.50 12-month price target, implying 12% upside.” Baird downgrades Roku to neutral from outperform Baird downgraded Roku on valuation. “Downgrading to Neutral rating and removing as Best Idea. Following the recent run, we are stepping to the sidelines on a less attractive risk/reward.” CLSA initiates Coupang as outperform CLSA said the sell-off in the Asia tech company is overdone. “Coupang’s recent correction following the data breach looks overdone, in our view.” BTIG initiates ICU Medical as buy BTIG said the med tech company is at a “cash flow inflection.” “We are initiating coverage o f ICU Medical (ICUI) with a Buy rating and a $170 price target. ICU Medical is a pure-play infusion therapy company operating in one of healthcare’s most structurally defensive markets.” Canaccord initiates Twist Bioscience as buy The firm said the biotech company has plenty of upside. “We are initiating coverage of Twist Bioscience ( TWST) with a BUY rating and a 12- month price target of $90.” Compass Point initiates Brookdale Senior Living as buy Compass said the senior living real estate company is firing on all cylinders. “We are initiating Brookdale Senior Living (B KD) at Buy with a $22 PT…” Melius reiterates Nvidia as buy Melius said Nvidia is on a “collision course” with Alphabet. “We are still in the early innings of AI agents for digital workers, but physical AI will be huge too. This category should help many in our coverage from AI semis to clouds. The category plays right into Nvidia’s hands given its full stack infrastructure that includes the software and world models to drive enterprise adoption putting it on a collision course with GOOGL.” Truist upgrades Datadog to buy from hold Truist said it sees several positive catalysts ahead. “We are upgrading DDOG to Buy. While the rating is consensus, it’s the underlying work that points to a path higher that differentiates our call. Our recent fieldwork revealed key incremental positives.”
